文献速递关节外科

重新审视初次全膝关节置换术并发症的国际标准化比值(INR)阈值:21239例分析

Revisiting the International Normalized Ratio (INR) Threshold for Complications in Primary Total Knee Arthroplasty: An Analysis of 21,239 Cases.
PubMed 文献 · J Bone Joint Surg Am · 2019-01-01

该回顾性研究基于美国外科医师学会国家手术质量改进计划(NSQIP)数据库2010至2016年21239例初次全膝关节置换术(TKA)患者,分析术前1天内记录的INR与围手术期出血、30天死亡率、感染、住院时间(LOS)和再入院的关系。多因素回归调整后,INR>1.0至1.25、>1.25至1.5和>1.5组相对INR≤1.0组的出血风险比值比(OR)分别为1.19、1.29和2.02;INR>1.5组感染OR为5.34;仅INR>1.25至1.5组死亡率OR为3.37;INR>1.25至1.5或>1.5组总体和TKA相关再入院率及LOS显著增加。作者结论认为现行共识指南的INR目标推荐应重新考虑。

要点

  • INR>1.0至1.25、>1.25至1.5和>1.5组相对INR≤1.0组的出血OR分别为1.19、1.29和2.02。
  • INR>1.5组感染OR为5.34(95%CI 2.45至11.68,p<0.001),相对INR≤1.0组。
  • 仅INR>1.25至1.5组死亡率OR为3.37(95%CI 1.31至8.63,p=0.011),相对INR≤1.0组。

核心结论

  • INR>1.25至1.5与TKA后出血、感染和死亡率增加相关,INR>1.5与出血和感染率增加相关。
  • 作者认为现行共识指南的INR目标推荐应重新考虑。

研究设计与样本

  • 回顾性分析美国外科医师学会国家手术质量改进计划(NSQIP)数据库2010至2016年接受初次TKA的成年患者。
  • 纳入术前1天内记录INR的患者,按INR分层分析围手术期出血、30天死亡率、深部和浅表感染、LOS及再入院。
  • 采用多因素回归调整INR组间人口学和合并症差异。
  • 证据等级为预后Level IV。

主要发现

  • 21239例患者中,57.2% INR≤1.0,38.1% INR>1.0至1.25,3.9% INR>1.25至1.5,0.8% INR>1.5。
  • 调整后相对INR≤1.0组,出血风险随INR升高而增加:INR>1.0至1.25组OR=1.19(95%CI 1.07至1.31,p=0.001),INR>1.25至1.5组OR=1.29(95%CI 1.02至1.63,p=0.033),INR>1.5组OR=2.02(95%CI 1.29至3.14,p=0.002)。
  • 相对INR≤1.0组,INR>1.5组感染风险增加(OR=5.34,95%CI 2.45至11.68,p<0.001)。
  • 相对INR≤1.0组,仅INR>1.25至1.5组死亡率风险增加(OR=3.37,95%CI 1.31至8.63,p=0.011)。
  • INR>1.25至1.5或INR>1.5组总体和TKA相关再入院率及LOS显著增加。

关键数值与推荐

  • 出血风险:相对INR≤1.0组,INR>1.0至1.25组OR=1.19(95%CI 1.07至1.31,p=0.001),INR>1.25至1.5组OR=1.29(95%CI 1.02至1.63,p=0.033),INR>1.5组OR=2.02(95%CI 1.29至3.14,p=0.002)。
  • 感染风险:相对INR≤1.0组,INR>1.5组OR=5.34(95%CI 2.45至11.68,p<0.001)。
  • 死亡风险:相对INR≤1.0组,仅INR>1.25至1.5组OR=3.37(95%CI 1.31至8.63,p=0.011)。
  • 再入院与LOS:INR>1.25至1.5或INR>1.5组总体和TKA相关再入院率及LOS显著增加。

临床怎么用

  • 作者认为现行共识指南的INR目标推荐应重新考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Consensus guidelines recommend use of the international normalized ratio (INR) to predict the risk of perioperative bleeding in orthopaedic surgery. However, current recommendations for targeting an INR of <1.5 are based on studies across all surgical disciplines. This study examined the impact of the INR on perioperative bleeding, mortality, postoperative infections, length of hospital stay (LOS), and readmissions following primary total knee arthroplasty (TKA). METHODS: We retrospectively reviewed the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database for adult patients who underwent primary TKA from 2010 to 2016. Patients for whom an INR had been recorded within 1 day before the surgery were stratified and analyzed for perioperative bleeding, mortality within 30 days, deep wound and superficial infections, LOS, and readmissions. Multivariable regressions were utilized to adjust for differences in demographics and comorbidities among INR groups. RESULTS: Of 21,239 patients, 57.2% had an INR of ≤1.0; 38.1% had an INR of >1.0 to 1.25, 3.9% had an INR of >1.25 to 1.5, and 0.8% had an INR of >1.5. After adjustment, a progressively increased bleeding risk was found with an INR of >1.0 to 1.25 (odds ratio [OR] = 1.19, 95% confidence interval [CI] = 1.07 to 1.31, p = 0.001), an INR of >1.25 to 1.5 (OR = 1.29, 95% CI = 1.02 to 1.63, p = 0.033), and an INR of >1.5 (OR = 2.02, 95% CI = 1.29 to 3.14, p = 0.002) relative to an INR of ≤1.0. Patients with an INR of >1.5 were at increased risk for infection (OR = 5.34, 95% CI = 2.45 to 11.68, p < 0.001), but only patients with an INR of >1.25 to 1.5 were at increased risk for mortality (OR = 3.37, 95% CI = 1.31 to 8.63, p = 0.011) relative to those with an INR of ≤1.0. Overall and TKA-related readmission rates and LOS were significantly increased for patients with an INR of >1.25 to 1.5 or an INR of >1.5. CONCLUSIONS: An INR of >1.25 to 1.5 was associated with increased bleeding, infection, and mortality rates following TKA, and an INR of >1.5 was associated with increased bleeding and infection rates. Current INR target recommendations in consensus guidelines should be reconsidered. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Rudasill SE, Liu J, Kamath AF, et al. Revisiting the International Normalized Ratio (INR) Threshold for Complications in Primary Total Knee Arthroplasty: An Analysis of 21,239 Cases. J Bone Joint Surg Am. 2019. PMID: 30893232. doi:10.2106/JBJS.18.00771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。